IKNA
Ikena Oncology (IKNA)
$70
About Ikena Oncology (IKNA)
Ikena Oncology, Inc. is a clinical stage biotechnology company, which engages in the development of patient directed and biomarker driven therapies for cancer patients. Its product pipeline includes IK-930, RAS Signaling, IK-175, IK-412, and IK-007. The company was founded by Mark Manfredi and George Georgiou in February 2016 and is headquartered in Boston, MA.
Details
Daily high
$1.72
Daily low
$1.68
Price at open
$1.68
52 Week High
$4.62
52 Week Low
$1.02
Market cap
82.0M
Dividend yield
0.00%
Volume
21,303
Avg. volume
33,181
P/E ratio
-1.19
Ikena Oncology News
Details
Daily high
$1.72
Daily low
$1.68
Price at open
$1.68
52 Week High
$4.62
52 Week Low
$1.02
Market cap
82.0M
Dividend yield
0.00%
Volume
21,303
Avg. volume
33,181
P/E ratio
-1.19